Home Compare ADYEN.AS vs PFE
Stock Comparison · Comparison

Adyen N.V. vs Pfizer: Which Stock Looks Stronger in 2026?

Adyen holds the cleaner structural position, with the lead spread across profitability and growth. Pfizer still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. In the market, Pfizer carries the stronger setup — intact trend against Adyen's broken trend. That leaves a split case: the structural lead stays with Adyen, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The result is anchored in profitability, but growth also reinforces the same direction. Adyen N.V. leads by 15 points on the overall comparison score.

Trajectory Similarity
0.57
Moderately similar
Peer-set rank: #6
within Adyen N.V.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The match is driven mainly by capital structure and margin consistency.

Similarity drivers
capital structuremargin consistency
What reduces the match
margin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
ADYEN.AS
Adyen N.V.
57
Peer-Score
Signal qualityHigh
vs
PFE
Pfizer Inc.
42
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: ADYEN.AS vs PFE Profitability 87 12 Stability 23 48 Valuation 53 82 Growth 55 19 ADYEN.AS PFE
Gap Ranking
#1 Profitability +75
#2 Growth +36
#3 Valuation +29
#4 Stability +25
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ADYEN.AS and PFE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ADYEN.ASPFE Relative valuation Structural strength

Adyen N.V. looks stronger, but the price setup still looks more supportive for Pfizer Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Adyen N.V. ranks near the top of the group on profitability; Pfizer Inc. sits in the weaker half.
Growth
Adyen N.V. sits in the stronger part of the group on growth, while Pfizer Inc. is closer to mid-pack.
Profitability — Dominant Gap
ADYEN.AS
87
PFE
12
Gap+75in favour of ADYEN.AS

The profitability lead is mainly driven by a 26-point operating margin advantage.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Pfizer, with a forward P/E that is 8.1 turns lower there.

What this means for the comparison

The lead is built on both profitability and growth — though valuation still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the ADYEN.AS vs PFE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how ADYEN.AS and PFE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.